Compare GOAI & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOAI | TMCI |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.7M | 120.4M |
| IPO Year | N/A | 2021 |
| Metric | GOAI | TMCI |
|---|---|---|
| Price | $2.48 | $4.14 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.77 |
| AVG Volume (30 Days) | 121.5K | ★ 636.3K |
| Earning Date | 04-10-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $212,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.18 |
| P/E Ratio | $18.31 | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $2.07 | $1.17 |
| 52 Week High | $6.67 | $7.78 |
| Indicator | GOAI | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 34.40 | 72.19 |
| Support Level | N/A | $2.46 |
| Resistance Level | $4.36 | $7.08 |
| Average True Range (ATR) | 0.45 | 0.31 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 18.42 | 81.08 |
Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.